Rodino-Klapac Louise (CIK 1836218) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-08). Recent activity: Sell SRPT (21,423 shares), Sell SRPT (948 shares), Sell SRPT (504 shares), Sell SRPT (895 shares), Buy SRPT (8,125 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-08 | Sarepta Therapeutics, Inc. (SRPT) | President, R&D and Tech Ops | Sell | 21,423 | $476,019 |
| 2026-03-13 | Sarepta Therapeutics, Inc. (SRPT) | President, R&D and Tech Ops | Sell | 948 | $16,144 |
| 2026-03-11 | Sarepta Therapeutics, Inc. (SRPT) | President, R&D and Tech Ops | Sell | 504 | $8,543 |
| 2026-03-11 | Sarepta Therapeutics, Inc. (SRPT) | President, R&D and Tech Ops | Sell | 895 | $15,170 |
| 2026-03-03 | Sarepta Therapeutics, Inc. (SRPT) | President, R&D and Tech Ops | Buy | 8,125 | $0 |
| 2026-03-03 | Sarepta Therapeutics, Inc. (SRPT) | President, R&D and Tech Ops | Sell | 3,718 | $60,232 |
| 2026-03-03 | Sarepta Therapeutics, Inc. (SRPT) | President, R&D and Tech Ops | Sell | 767 | $12,425 |
| 2025-11-19 | Sarepta Therapeutics, Inc. (SRPT) | President, R&D and Tech Ops | Sell | 4,582 | $84,400 |
| 2025-09-05 | Sarepta Therapeutics, Inc. (SRPT) | President, R&D and Tech Ops | Buy | 93,875 | $0 |
| 2025-09-05 | Sarepta Therapeutics, Inc. (SRPT) | President, R&D and Tech Ops | Buy | 50,000 | $0 |
来源：SEC Form 4 申报文件 · 截至 2026-09-08